ES2052914T3 - Un procedimiento para preparar un complejo de beta-dextrina con una sal de ibuprofeno. - Google Patents

Un procedimiento para preparar un complejo de beta-dextrina con una sal de ibuprofeno.

Info

Publication number
ES2052914T3
ES2052914T3 ES89305535T ES89305535T ES2052914T3 ES 2052914 T3 ES2052914 T3 ES 2052914T3 ES 89305535 T ES89305535 T ES 89305535T ES 89305535 T ES89305535 T ES 89305535T ES 2052914 T3 ES2052914 T3 ES 2052914T3
Authority
ES
Spain
Prior art keywords
beta
salt
preparing
ibuprophen
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89305535T
Other languages
English (en)
Spanish (es)
Inventor
Christopher Hunter
David Yau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt and Colman Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt and Colman Products Ltd filed Critical Reckitt and Colman Products Ltd
Application granted granted Critical
Publication of ES2052914T3 publication Critical patent/ES2052914T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ES89305535T 1988-06-09 1989-06-01 Un procedimiento para preparar un complejo de beta-dextrina con una sal de ibuprofeno. Expired - Lifetime ES2052914T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813682A GB8813682D0 (en) 1988-06-09 1988-06-09 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2052914T3 true ES2052914T3 (es) 1994-07-16

Family

ID=10638367

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89305535T Expired - Lifetime ES2052914T3 (es) 1988-06-09 1989-06-01 Un procedimiento para preparar un complejo de beta-dextrina con una sal de ibuprofeno.

Country Status (18)

Country Link
US (1) US5019563A (cg-RX-API-DMAC10.html)
EP (1) EP0346006B1 (cg-RX-API-DMAC10.html)
JP (1) JPH02243649A (cg-RX-API-DMAC10.html)
KR (1) KR910000138A (cg-RX-API-DMAC10.html)
AT (1) ATE83924T1 (cg-RX-API-DMAC10.html)
AU (1) AU609988B2 (cg-RX-API-DMAC10.html)
CA (1) CA1320192C (cg-RX-API-DMAC10.html)
DE (1) DE68904121T2 (cg-RX-API-DMAC10.html)
DK (1) DK280789A (cg-RX-API-DMAC10.html)
ES (1) ES2052914T3 (cg-RX-API-DMAC10.html)
FI (1) FI93692C (cg-RX-API-DMAC10.html)
GB (2) GB8813682D0 (cg-RX-API-DMAC10.html)
GR (1) GR3006729T3 (cg-RX-API-DMAC10.html)
IE (1) IE61616B1 (cg-RX-API-DMAC10.html)
NO (1) NO175039B (cg-RX-API-DMAC10.html)
NZ (1) NZ229204A (cg-RX-API-DMAC10.html)
PT (1) PT90760B (cg-RX-API-DMAC10.html)
ZA (1) ZA893913B (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2171110A1 (es) * 2000-03-03 2002-08-16 Aplicaciones Farmacodinamicas Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
FR2660195B1 (fr) * 1990-03-28 1994-10-07 Crinex Sa Laboratoires Composition pharmaceutique a macher, antiinflammatoire et/ou analgesique.
ES2093192T3 (es) * 1991-03-22 1996-12-16 Merck & Co Inc Formulacion farmaceutica con elevado contenido de lisinato de ibuprofeno.
EP0519428B1 (en) * 1991-06-21 2000-09-20 Takeda Chemical Industries, Ltd. Cyclodextrin compositions with fumagillol derivates
US5321014A (en) * 1991-06-28 1994-06-14 The United States Of America As Represented By The Department Of Health And Human Services Molecular encapsulation and delivery of alkenes alkynes and long chain alkanes, to living mammalian cells
IT1255007B (it) * 1991-07-01 1995-10-11 Altergon Sa Sale solubile dell'ibuprofen c0n n-(2-idrossietil) pirrolidina e composizioni farmaceutiche che li contengono.
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
IT1272149B (it) * 1993-03-26 1997-06-11 Zambon Spa Composizione farmeceutiche ad attivita' analgesica
HU210922B (en) * 1993-05-24 1995-09-28 Europharmaceuticals Sa Nimesulide alkali salt cyclodextrin inclusion complexes their preparation and pharmaceutical compositions containing them
CN1088600C (zh) * 1993-07-31 2002-08-07 史密丝克莱恩比彻姆有限公司 布洛芬-β-环糊精配合物的用途
US5582351A (en) * 1993-08-09 1996-12-10 Tsau; Josef Convenient to use aspartame and method of making
US5866162A (en) * 1993-08-10 1999-02-02 Smithkline Beecham P.L.C. Pharmaceutical composition containing a drug/β-cyclodextrin complex in combination with an acid-base couple
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
NZ270077A (en) * 1993-12-14 1996-04-26 Lilly Co Eli Aqueous complexes of benzothiophenes and cyclodextrins
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
EP0760680A1 (en) * 1994-05-27 1997-03-12 Farmarc Nederland Bv Pharmaceutical composition
BE1008307A3 (fr) * 1994-06-16 1996-04-02 Europharmaceuticals Sa Sel de nimesulide hydrosoluble, solution aqueuse le contenant, sa preparation et son utilisation.
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
US5942501A (en) * 1996-08-16 1999-08-24 Collaborative Laboratories, Inc. Cyclodextrin derivative complex
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6287603B1 (en) * 1999-09-16 2001-09-11 Nestec S.A. Cyclodextrin flavor delivery systems
US7141555B2 (en) * 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
KR100451485B1 (ko) * 2002-03-28 2004-10-06 주식회사종근당 푸마질롤 유도체 또는 그 염의 포접 화합물, 및 이를포함하는 약제학적 조성물
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
PL381799A1 (pl) * 2004-06-07 2007-07-09 Strides Arcolab Limited Kompozycja farmaceutyczna zawierająca trwały i klarowny roztwór leku przeciwzapalnego w miękkiej kapsułce żelatynowej i sposób jej wytwarzania
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
KR100730393B1 (ko) * 2005-06-10 2007-06-20 한국콜마 주식회사 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법
CA2620219A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
AU2007227614B2 (en) * 2006-03-16 2011-01-06 Gsk Consumer Healthcare Sarl Solid dosage form containing a taste masked active agent
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
EP2323976A4 (en) * 2008-08-14 2014-07-02 Shasun Chemicals And Drugs Ltd ARYLALKYLCARBOXYLIC ACID SALTS, PROCESS FOR PREPARATION THEREOF AND GALENIC FORMS
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
ES2608060T3 (es) * 2009-04-27 2017-04-05 Laboratorio De Aplicaciones Farmacodinamicas, S.A. Suspensión oral de Lisinato de Ibuprofeno
CN102448499A (zh) * 2009-04-27 2012-05-09 药效学应用实验室股份有限公司 赖氨酸布洛芬口服混悬剂
ES2347754B8 (es) * 2009-04-27 2012-06-04 Laboratorio De Aplicaciones Farmacodinamicas, S.A Suspension oral de lisinato de ibuprofeno
RU2011150661A (ru) * 2009-06-22 2013-07-27 ВАЙЕТ ЭлЭлСи Таблетки ибупрофена натрия и способы изготовления фармацевтических композиций, включающих ибупрофен натрия
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法
US10098964B2 (en) 2015-03-12 2018-10-16 The Board Of Trustees Of The University Of Illinois Inclusion complexes and methods for making the same
CN114588107B (zh) * 2022-04-06 2023-04-18 河北一品生物医药有限公司 一种布洛芬赖氨酸盐注射液及其制备方法
GR1010732B (el) * 2023-06-02 2024-07-25 Ιουλια Κλεωνος Τσετη Φαρμακευτικη συνθεση ιβουπροφαινης και παρακεταμολης για απο του στοματος χορηγηση

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646837A (en) * 1979-09-27 1981-04-28 Kowa Yakuhin Kogyo Kk Preparation of ibuprofen clathrate compound
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
CA1298290C (en) * 1987-01-09 1992-03-31 Herand M. Markarian Solution ibuprofen complexes, compositions and processes for preparing the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2171110A1 (es) * 2000-03-03 2002-08-16 Aplicaciones Farmacodinamicas Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.

Also Published As

Publication number Publication date
NO175039C (cg-RX-API-DMAC10.html) 1994-08-24
PT90760B (pt) 1994-10-31
DK280789A (da) 1989-12-12
US5019563A (en) 1991-05-28
FI93692C (fi) 1995-05-26
AU3492789A (en) 1989-12-14
FI892780A0 (fi) 1989-06-07
DE68904121D1 (de) 1993-02-11
GB8911938D0 (en) 1989-07-12
JPH02243649A (ja) 1990-09-27
DK280789D0 (da) 1989-06-08
DE68904121T2 (de) 1993-05-06
GB2219585B (en) 1991-11-06
EP0346006B1 (en) 1992-12-30
ZA893913B (en) 1990-02-28
NO175039B (no) 1994-05-16
PT90760A (pt) 1989-12-29
GB2219585A (en) 1989-12-13
FI892780L (fi) 1989-12-10
NO892340L (no) 1989-12-11
IE61616B1 (en) 1994-11-16
GB8813682D0 (en) 1988-07-13
NZ229204A (en) 1992-03-26
AU609988B2 (en) 1991-05-09
CA1320192C (en) 1993-07-13
EP0346006A1 (en) 1989-12-13
GR3006729T3 (cg-RX-API-DMAC10.html) 1993-06-30
NO892340D0 (no) 1989-06-07
IE891757L (en) 1989-12-09
ATE83924T1 (de) 1993-01-15
FI93692B (fi) 1995-02-15
KR910000138A (ko) 1991-01-29

Similar Documents

Publication Publication Date Title
ES2052914T3 (es) Un procedimiento para preparar un complejo de beta-dextrina con una sal de ibuprofeno.
ES8403316A1 (es) Un procedimiento para la preparacion de una composicion a base de sales de cinc y sales de fluoruro.
ES553714A0 (es) Procedimiento para la preparacion de una composicion que contiene una sal de acido hialuronico.
ES2035086T3 (es) Procedimiento para preparar una composicion solida y estable que contiene ibuprofeno y codeina.
ES2040847T3 (es) Un procedimiento para preparar una composicion farmaceutica que contiene una sal de litio.
IS3339A7 (is) Ný efnablanda lyfja
MX148599A (es) Mejoras a un instrumento medico para introducir una droga en la cavidad uterina de las mujeres
IT8722783A0 (it) Procedimento di sintesi dell'amikacina
ES2037095T3 (es) Un procedimiento para preparar una composicion farmaceutica.
MX5959E (es) Procedimiento para la preparacion de composiciones farmaceuticas estables que contiene quelatos de oxitetraciclina,magnesio y calcio,en una solucion de 2-pirrolidona acuosa
IT7829910A0 (it) Derivati dell'acido fosfonoso, procedimenti per la loro preparazione e loro impiego per combattere microorganismi.
ES493481A0 (es) Procedimiento para preparar 2,7-dioxo-2,7-dihidroben- zo-(1:2-b;5:6-b1)difurano o -dipirrol
PT86644A (pt) Process for the preparation of dry formulations containing a salt of diclofenac
PT88681A (pt) A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives
MX159874A (es) Procedimiento para preparar una composicion farmaceutica a base de fosfolipidos
ES2020925B3 (es) Nuevas sales cristalinas de ariloxipropanolaminas, procedimiento para su preparacion y utilizacion de las mismas.
DK654888A (da) Farmaceutiske praeprarater indeholdende nedocromilnatrium
MX9302711A (es) Preparacion de base.
MX150838A (es) Mejoras en capsula dental desechable para preparar amalgama
MX3789E (es) Procedemiento para la preparacion de una aleacion dental
IT8024152A0 (it) Derivati dell'1,1,2-trifenilpropano e dell'1,1,2-trifenilpropene, procedimento per la loro preparazione e composizioni farmaceutiche contenenti i composti
GB1554783A (en) Pharmaceutical compositions for use in the permanent sterilization of female animals
ES2053590T3 (es) 3-fenil-7h-tiazolo(3,2-b)(1,2,4)triazin-7-onas sustituidas, procedimiento para su preparacion, medicamentos que las contienen y su empleo, asi como algunos productos intermedios formados durante la preparacion de los compuestos mencionados.
MX174093B (es) 1,1-DIOXIDOS DE 3,4-DIHIDRO-2-ALQUIL-3-OXO-N-ARIL-2H[1] BENZOTIENO[3,2-e]-1,2-TIAZINO-4-CARBOXIAMIDA
ES248206Y (es) Pequeno mueble destinado para contener articulos para la hi-giene oral

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 346006

Country of ref document: ES